ATE254611T1 - N-arylmethylthioanilid-derivate für die hemmung der hiv-replikation - Google Patents

N-arylmethylthioanilid-derivate für die hemmung der hiv-replikation

Info

Publication number
ATE254611T1
ATE254611T1 AT00963380T AT00963380T ATE254611T1 AT E254611 T1 ATE254611 T1 AT E254611T1 AT 00963380 T AT00963380 T AT 00963380T AT 00963380 T AT00963380 T AT 00963380T AT E254611 T1 ATE254611 T1 AT E254611T1
Authority
AT
Austria
Prior art keywords
arylmethylthioanilide
derivatives
hiv replication
inhibiting hiv
replication
Prior art date
Application number
AT00963380T
Other languages
English (en)
Inventor
Walter Gerhard Brouwer
Ewa Maria Osika
Original Assignee
Uniroyal Chem Co Inc
Crompton Co Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Chem Co Inc, Crompton Co Cie filed Critical Uniroyal Chem Co Inc
Application granted granted Critical
Publication of ATE254611T1 publication Critical patent/ATE254611T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00963380T 1999-09-17 2000-09-12 N-arylmethylthioanilid-derivate für die hemmung der hiv-replikation ATE254611T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/398,649 US6143780A (en) 1999-09-17 1999-09-17 N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV
PCT/US2000/024986 WO2001019811A2 (en) 1999-09-17 2000-09-12 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv

Publications (1)

Publication Number Publication Date
ATE254611T1 true ATE254611T1 (de) 2003-12-15

Family

ID=23576222

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00963380T ATE254611T1 (de) 1999-09-17 2000-09-12 N-arylmethylthioanilid-derivate für die hemmung der hiv-replikation

Country Status (8)

Country Link
US (1) US6143780A (de)
EP (1) EP1220848B1 (de)
AT (1) ATE254611T1 (de)
CA (1) CA2384134C (de)
DE (1) DE60006706T2 (de)
DK (1) DK1220848T3 (de)
ES (1) ES2211608T3 (de)
WO (1) WO2001019811A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050111306A (ko) 2002-11-19 2005-11-24 아칠리온 파르마세우티칼스 인코포레이티드 바이러스 복제 억제제로서의 치환된 아릴 티오우레아 및관련 화합물
DE102006052504A1 (de) 2006-11-06 2008-05-08 Temper, Rupert Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit
US8461161B2 (en) * 2006-11-15 2013-06-11 Ym Biosciences Australia Pty Ltd Substituted pyrazines as inhibitors of kinase activity
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
EP2414830A2 (de) * 2009-03-31 2012-02-08 Robert Zimmermann Atgl(adipose triglyceride lipase )-modulation zur vorbeugung und behandlung von kachexie, gewichtsverlust und muskelatrophie sowie screening-verfahren dafür
EP3743063A4 (de) * 2018-01-26 2021-10-20 Nurix Therapeutics, Inc. Inhibitoren von cbl-b und verfahren zu deren verwendung
CA3136348A1 (en) 2019-04-09 2020-10-15 Nurix Therapeutics, Inc. 3-substituted piperidine compounds for cbl-b inhibition, and use of a cbl-b inhibitor in combination with a cancer vaccine and/or oncolytic virus
US20250346567A1 (en) * 2024-05-13 2025-11-13 Pfizer Inc. Substituted pyridine and phenyl compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696151A (en) * 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
US6017947A (en) * 1999-09-17 2000-01-25 Brouwer; Walter Gerhard Heterocyclic carbodithioperoxyimidic compounds useful for the inhibition of the replication of HIV

Also Published As

Publication number Publication date
US6143780A (en) 2000-11-07
WO2001019811A3 (en) 2001-07-26
DE60006706T2 (de) 2004-08-19
ES2211608T3 (es) 2004-07-16
DE60006706D1 (de) 2003-12-24
WO2001019811A2 (en) 2001-03-22
EP1220848A2 (de) 2002-07-10
CA2384134A1 (en) 2001-03-22
DK1220848T3 (da) 2004-03-29
EP1220848B1 (de) 2003-11-19
CA2384134C (en) 2011-01-18

Similar Documents

Publication Publication Date Title
NO953305D0 (no) Antranilsyrederivat
DK1054874T3 (da) Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
NO20023097L (no) Heterocykliske forbindelser med sulfonamidgrupper
EP1191931A4 (de) 1-(4-sulfamylaryl)-3-substituierte 5-aryl-2-pyrazoline als gyclooxygenase-2 inhibitoren
DK0769010T3 (da) 2-[1',2',4'-triazol-3'-yloxymethylen]-anilider og deres anvendelse som pesticider
DE60006706D1 (de) N-arylmethylthioanilid-derivate für die hemmung der hiv-replikation
DE69319614D1 (de) 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren
UY24802A1 (es) Nuevos compuestos
ATE269851T1 (de) Benzimidazole derivate
EP1144393A3 (de) Heterocyclische derivate und ihre verwendung als integrininhibitore
DE59908317D1 (de) 2-arylalkylthio -imidazole, 2-arylalkenyl -thio -imidazole und 2-arylalkinyl -thio -imidazole als entzündungs -hemmstoffe und hemmstoffe der cytokin -freisetzung
DK372285A (da) Pesticidt virksomme urinstofderivater
BR0215911A (pt) Compostos 1,2,4-tiadiazol e utilização dos mesmos
IL84300A0 (en) 1-carbamoyl-2-pyrazoline derivatives,their preparation and their use as herbicides
EP1431293A4 (de) Wasserlösliche phenylpyridazinderivate und diese enthaltende arzneimittel
TR199600181A2 (tr) 4-alkiltio-pirimidin-5-ilasetik asit türevleri.
MXPA02012072A (es) Derivados de 4,5-dihidro-tiazol-2-ilamina y su uso como inhibidores de no-sintasa.
ES2112774A1 (es) Nuevos derivados azolicos con actividad antifungica.
TH52198A (th) สารประกอบไตรไซคลิกที่ถูกแทนที่

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220848

Country of ref document: EP